SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-08 17:38
Tx date 2024-03-04
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-35,000 vol
643,021
Filed 2024-03-07 11:49
Tx date 2024-03-07
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,000
+20,000 vol
$0.50 each
1,003,296
Filed 2023-09-15 17:24
Tx date 2023-09-12
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+255,000 vol
678,021
Filed 2023-06-16 12:40
Tx date 2023-06-15
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
56 - Grant of rights

+32,979 vol
32,979
Filed 2023-06-16 12:38
Tx date 2023-06-15
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$15,829
+98,935 vol
$0.16 each
223,843
Filed 2023-06-09 13:15
Tx date 2023-06-07
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$2,083
+13,889 vol
$0.15 each
90,139
Filed 2023-06-09 13:15
Tx date 2023-06-07
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
57 - Exercise of rights

-13,889 vol
0
Filed 2022-11-19 11:41
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
423,021
Filed 2022-11-16 19:56
Tx date 2022-11-15
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,400
+40,000 vol
$0.485 each
983,296
Filed 2022-07-14 21:06
Tx date 2022-02-27
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants

-4,000 vol
1,750
Filed 2022-07-13 13:47
Tx date 2022-06-16
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
38 - Redemption, retraction, cancellation, repurchase

-1,750 vol
4,000
Filed 2022-07-12 19:24
Tx date 2022-07-12
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,600
+30,000 vol
$0.62 each
943,296
Filed 2022-07-12 19:17
Tx date 2022-07-11
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,190
+24,500 vol
$0.62 each
913,296
Filed 2022-07-12 19:16
Tx date 2022-07-11
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,500
+7,500 vol
$0.60 each
888,796
Filed 2022-06-29 15:50
Tx date 2022-05-31
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
56 - Grant of rights
$6,250
+13,889 vol
$0.45 each
13,889
Filed 2022-06-29 15:49
Tx date 2022-05-31
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+41,666 vol
124,908
Filed 2021-11-19 20:33
Tx date 2021-11-15
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+85,000 vol
1,277,200
Filed 2021-11-01 19:27
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$33,320
+34,000 vol
$0.98 each
881,296
Filed 2021-11-01 19:26
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$26,600
+28,000 vol
$0.95 each
847,296
Filed 2021-11-01 19:25
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,290
+3,500 vol
$0.94 each
819,296
Filed 2021-11-01 19:24
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$34,410
+37,000 vol
$0.93 each
815,796
Filed 2021-11-01 19:23
Tx date 2021-11-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,300
+2,500 vol
$0.92 each
778,796
Filed 2021-09-16 09:55
Tx date 2021-09-09
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+6,250 vol
76,250
Filed 2021-09-16 09:53
Tx date 2021-09-09
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
57 - Exercise of rights

-6,250 vol
0
Filed 2021-09-01 11:22
Tx date 2021-08-31
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,600
+20,000 vol
$0.63 each
70,000
Filed 2021-08-05 18:02
Tx date 2021-08-04
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,750
+12,500 vol
$1.02 each
776,296
Filed 2021-07-15 19:57
Tx date 2021-07-13
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,280
+4,000 vol
$3.57 each
763,796
Filed 2021-07-04 17:20
Tx date 2021-06-30
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,800
+4,000 vol
$3.70 each
759,796
Filed 2021-06-06 16:11
Tx date 2021-06-02
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$205,506
+46,458 vol
$4.42 each
126,100
Filed 2021-06-06 16:09
Tx date 2021-06-02
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$2,637,909
+596,340 vol
$4.42 each
830,796
Filed 2021-06-06 16:02
Tx date 2021-06-03
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-300,300
-75,000 vol
$4.00 each
755,796
Filed 2021-03-06 12:45
Tx date 2021-03-03
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$38,861
+7,546 vol
$5.15 each
79,642
Filed 2021-03-06 12:44
Tx date 2021-03-03
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$153,171
+29,742 vol
$5.15 each
234,456
Filed 2021-03-03 20:13
Tx date 2021-03-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$116,210
+21,968 vol
$5.29 each
72,096
Filed 2021-03-03 20:12
Tx date 2021-03-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$457,987
+86,576 vol
$5.29 each
204,714
Filed 2021-02-27 16:55
Tx date 2021-02-23
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately
$130,541
+20,461 vol
$6.38 each
50,128
Filed 2021-02-27 16:54
Tx date 2021-02-23
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$514,470
+80,638 vol
$6.38 each
118,138
Filed 2021-01-15 18:44
Tx date 2021-01-11
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+513,200 vol
1,192,200
Filed 2020-12-17 18:23
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-51,750 vol
5,750
Filed 2020-12-17 18:21
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
37 - Stock split or consolidation

-6,111,000 vol
679,000
Filed 2020-12-17 18:20
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-3,042,185 vol
338,021
Filed 2020-12-17 18:19
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Indirect Ownership)
Common Shares
37 - Stock split or consolidation

-266,999 vol
29,667
Filed 2020-12-17 18:17
Tx date 2020-12-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-337,500 vol
37,500
Filed 2020-09-24 13:28
Tx date 2020-09-24
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$25,500
+75,000 vol
$0.34 each
375,000
Filed 2020-09-04 16:44
Tx date 2020-09-01
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
56 - Grant of rights
$5,437
+6,250 vol
$0.87 each
6,250
Filed 2020-09-04 16:43
Tx date 2019-11-26
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Restricted Share Unit (RSU)
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-04 16:42
Tx date 2020-09-01
$NPTH
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$16,312
+18,750 vol
$0.87 each
83,242
Filed 2020-06-26 15:25
Tx date 2020-06-25
$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation

-257,966 vol
64,492
Filed 2020-06-26 15:25
Tx date 2020-06-25
$KHV
NeuPath Health Inc. (formerly, Klinik Health Ventures Corp.)
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-200,000 vol
50,000
Filed 2020-06-06 13:57
Tx date 2020-06-04
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-135,000
-225,000 vol
$0.60 each
300,000
Filed 2020-06-06 13:57
Tx date 2020-06-03
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-156,997.50
-259,500 vol
$0.60 each
525,000
Filed 2020-06-06 13:55
Tx date 2020-06-02
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,300
-15,500 vol
$0.60 each
784,500
Filed 2020-06-06 13:55
Tx date 2020-06-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-762,500
-1,250,000 vol
$0.61 each
800,000
Filed 2020-06-06 13:52
Tx date 2020-06-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$145,000
+1,000,000 vol
$0.145 each
2,050,000
Filed 2020-06-06 13:51
Tx date 2020-06-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$247,500
+750,000 vol
$0.33 each
1,050,000
Filed 2020-06-06 13:49
Tx date 2020-06-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-145,000
-1,000,000 vol
$0.145 each
3,380,206
Filed 2020-06-06 13:47
Tx date 2020-06-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-247,500
-750,000 vol
$0.33 each
4,380,206
Filed 2020-04-09 13:28
Tx date 2020-04-09
$
Klinik Health Ventures Corp.
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+89,958 vol
322,458
Filed 2019-12-03 15:16
Tx date 2019-12-03
$
Klinik Health Ventures Corp.
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+232,500 vol
232,500
Filed 2019-12-03 15:15
Tx date 2019-11-26
$
Klinik Health Ventures Corp.
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-03 15:15
Tx date 2019-11-26
$
Klinik Health Ventures Corp.
Legault, Daniel Marcel
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2019-11-28 13:19
Tx date 2019-11-28
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+2,040,000 vol
6,790,000
Filed 2019-08-14 14:09
Tx date 2019-08-13
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
$5,250
+17,500 vol
$0.30 each
57,500
Filed 2019-08-14 14:07
Tx date 2019-08-13
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$10,500
+35,000 vol
$0.30 each
300,000
Filed 2019-06-03 12:30
Tx date 2019-06-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Warrants
55 - Expiration of warrants

-180,000 vol
0
Filed 2019-05-13 15:17
Tx date 2019-05-13
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,900
+35,000 vol
$0.34 each
265,000
Filed 2019-02-27
Tx date 2019-02-25
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$20,000
+80,000 vol
$0.25 each
230,000
Filed 2019-02-27
Tx date 2013-06-10
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-27
Tx date 2019-02-25
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
15 - Acquisition or disposition under a prospectus
$10,000
+40,000 vol
$0.25 each
40,000
Filed 2018-11-28
Tx date 2018-11-27
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,500
+50,000 vol
$0.25 each
150,000
Filed 2018-10-05
Tx date 2013-06-10
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2018-10-05
Tx date 2018-10-03
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
97 - Other

+4,750,000 vol
4,750,000
Filed 2018-09-19
Tx date 2018-09-19
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$26,000
+100,000 vol
$0.26 each
100,000
Filed 2018-04-26
Tx date 2018-04-23
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale
$-101,015
-227,000 vol
$0.445 each
-227,000
Filed 2018-04-26
Tx date 2018-04-23
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale
$-5,160
-12,000 vol
$0.43 each
-600,000
Filed 2018-04-26
Tx date 2018-04-25
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$87,000
+600,000 vol
$0.145 each
0
Filed 2018-04-26
Tx date 2018-04-20
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-118,575
-255,000 vol
$0.465 each
296,666
Filed 2018-04-26
Tx date 2018-04-25
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-87,000
-600,000 vol
$0.145 each
5,130,206
Filed 2018-04-26
Tx date 2018-04-23
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale
$-12,397.50
-28,500 vol
$0.435 each
-588,000
Filed 2018-04-26
Tx date 2018-04-23
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale
$-146,300
-332,500 vol
$0.44 each
-559,500
Filed 2018-04-15
Tx date 2018-04-13
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$89,870
+619,794 vol
$0.145 each
0
Filed 2018-04-15
Tx date 2018-04-13
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-89,870.13
-619,794 vol
$0.145 each
5,730,206
Filed 2018-04-14
Tx date 2018-04-12
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale
$-90,549.06
-184,794 vol
$0.49 each
-619,794
Filed 2018-04-14
Tx date 2013-06-10
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-14
Tx date 2018-04-11
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
40 - Short sale
$-217,500
-435,000 vol
$0.50 each
-435,000
Filed 2018-03-25
Tx date 2017-12-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Warrants
55 - Expiration of warrants

-75,000 vol
Filed 2018-03-25
Tx date 2017-12-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Warrants
55 - Expiration of warrants

-75,000 vol
180,000
Filed 2018-03-23
Tx date 2017-12-01
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Schmed Enterprises Inc. (Control or Direction)
Warrants
55 - Expiration of warrants

-75,000 vol
180,000
Filed 2017-04-03
Tx date 2017-03-31
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$520,000
+2,600,000 vol
$0.20 each
6,350,000
Filed 2016-03-11
Tx date 2016-03-09
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$355,250
+2,450,000 vol
$0.145 each
3,750,000
Filed 2015-07-24
Tx date 2015-07-13
$ATE
Antibe Therapeutics Inc.
Legault, Daniel Marcel
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$28,000
+200,000 vol
$0.14 each
1,300,000